Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 452NIH 64INDUSTRY 57NETWORK 26OTHER_GOV 5FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Prostatic Neoplasms 17Rare Diseases 3Neoplasms 3Neoplasm Metastasis 3Leukemia 3Recurrence 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Genetic Diseases, Inborn 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Squamous Cell 2Adenocarcinoma Of Esophagus 2Turcot syndrome 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Respiratory Aspiration 1Radiation Pneumonitis 1Prostate Cancer Diagnosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatosis 2 1Neurofibromatoses 1

Interventions

Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × FED × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all
NCT00098033 2015-03-25

Investigation of Clofarabine in Acute Leukemias

FDA Office of Orphan Products Development

Phase 2 Completed
64 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡